Randomized Controlled Trial
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Lancet. 2014 Mar 22;383(9922):1049-58.
Randomized Controlled Trial
Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
J. Infect. Dis. 2016 Mar 1; 213 (5): 794-9.
Randomized Controlled Trial
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
Plos One. 2011 Jan 18; 6 (1): e14501.